In defence of polypharmacy

被引：40

作者：

Aronson, JK ^{[1
]}

机构：

[1] Univ Oxford, Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HE, England

来源：

关键词：

D O I：

10.1111/j.1365-2125.2004.02067.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：119 / 120

页数：2

共 6 条

[1]

ARONSON JK, 1985, ACCOUNT FOXGLOVE ITS, P268

[2] Automated signal generation in prescription-event monitoring [J].

Heeley, E ;

Wilton, LV ;

Shakir, SAW .

Movig, KLL ;

Leufkens, HGM ;

Lenderink, AW ;

van den Akker, VGA ;

Hodiamont, PPG ;

Goldschmidt, HMJ ;

Egberts, ACG .

Standl, E ;

Füchtenbusch, M .

[5] A strategy to reduce cardiovascular disease by more than 80% [J].

Wald, NJ ;

Law, MR .

BMJ-BRITISH MEDICAL JOURNAL, 2003, 326 (7404) :1419-1423

[6]

Watson Gilbert., 1966, THERIAC MITHRIDATIUM